Invest with Precision
We are looking for investors and innovative finance partners to tell us honestly what analyses would change how you evaluate and monitor investments in LMICs
Investors and Innovative Financiers
Better data. Bolder investments.
Investment decisions in global health markets are only as good as the intelligence behind them. Whether you are sizing a volume guarantee, underwriting a manufacturer, or building an impact portfolio across LMICs, the data you need to make those decisions with confidence has never existed in one place — until now.
Merlyn AI gives investors and innovative finance institutions the market intelligence, demand forecasting, and risk modelling they need to move faster, invest smarter, and demonstrate impact with rigour.
What you can do with Merlyn:
For guarantee providers and innovative finance — model probabilistic demand forecasts with confidence intervals to size guarantees and calculate default risk. Toggle key assumptions to run sensitivity analyses, stress-test scenarios, and quantify black swan risk. Build the risk appendix your investment committee requires, grounded in real market data rather than expert guesswork.
For development finance institutions — assess the commercial viability of manufacturers, hospital groups, and health businesses across LMICs with market sizing, revenue projections, and competitive positioning built on real order and pricing data. Quantify development impact — patients reached, lives saved, health system savings, jobs supported — in the format your impact framework requires.
For commercial and impact investors — size the market opportunity for health businesses operating in LMICs, model revenue trajectories across bull, base, and bear scenarios, and understand the operating environment risks that determine whether a business can actually execute on its plan.
The investments that will define the next era of global health are being made now. Merlyn ensures they are made on the best available evidence.
